These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1358571

  • 1. Pharmacokinetics of intravenously injected [3H]tetrachloro(D,L-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin) in mice.
    Kido Y, Khokhar AR, Siddik ZH.
    Drug Metab Dispos; 1992; 20(5):673-8. PubMed ID: 1358571
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.
    Kido Y, Khokhar AR, Yoshida M, Thai GW, Siddik ZH.
    Drug Metab Dispos; 1994; 22(2):312-7. PubMed ID: 8013287
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
    Rahman A, Roh JK, Wolpert-DeFilippes MK, Goldin A, Venditti JM, Woolley PV.
    Cancer Res; 1988 Apr 01; 48(7):1745-52. PubMed ID: 3162402
    [Abstract] [Full Text] [Related]

  • 4. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 01; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats.
    Luo FR, Wyrick SD, Chaney SG.
    Cancer Chemother Pharmacol; 1999 Nov 01; 44(1):19-28. PubMed ID: 10367745
    [Abstract] [Full Text] [Related]

  • 6. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH, al-Baker S, Thai G, Khokhar AR.
    Anticancer Drug Des; 1994 Apr 01; 9(2):139-51. PubMed ID: 8166929
    [Abstract] [Full Text] [Related]

  • 7. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 8. In vitro biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in rat plasma.
    Chaney SG, Wyrick S, Till GK.
    Cancer Res; 1990 Aug 01; 50(15):4539-45. PubMed ID: 2196115
    [Abstract] [Full Text] [Related]

  • 9. Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium.
    Gibbons GR, Wyrick S, Chaney SG.
    Cancer Res; 1989 Mar 15; 49(6):1402-7. PubMed ID: 2924297
    [Abstract] [Full Text] [Related]

  • 10. Comparisons of tetrachloro(d,l-trans)1,2-diaminocyclohexane-platinum(IV) biotransformations in the plasma of Fischer 344 rats at therapeutic and toxic doses.
    Carfagna PF, Poma A, Wyrick SD, Holbrook DJ, Chaney SG.
    Cancer Chemother Pharmacol; 1991 Mar 15; 27(5):335-41. PubMed ID: 1998992
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
    Vouillamoz-Lorenz S, Buclin T, Lejeune F, Bauer J, Leyvraz S, Decosterd LA.
    Anticancer Res; 2003 Mar 15; 23(3C):2757-65. PubMed ID: 12926110
    [Abstract] [Full Text] [Related]

  • 12. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y, Khokhar AR, al-Baker S, Siddik ZH.
    Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of carboplatin after i.v. administration.
    Elferink F, van der Vijgh WJ, Klein I, Vermorken JB, Gall HE, Pinedo HM.
    Cancer Treat Rep; 1987 Dec 01; 71(12):1231-7. PubMed ID: 3319135
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and tissue distribution of platinum in rats following single and multiple oral doses of LA-12 [(OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)].
    Sova P, Chladek J, Zak F, Mistr A, Kroutil A, Semerad M, Slovak Z.
    Int J Pharm; 2005 Jan 06; 288(1):123-9. PubMed ID: 15607264
    [Abstract] [Full Text] [Related]

  • 15. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.
    Mauldin SK, Gibbons G, Wyrick SD, Chaney SG.
    Cancer Res; 1988 Sep 15; 48(18):5136-44. PubMed ID: 3409241
    [Abstract] [Full Text] [Related]

  • 16. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
    Rice JR, Gerberich JL, Nowotnik DP, Howell SB.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2248-54. PubMed ID: 16609041
    [Abstract] [Full Text] [Related]

  • 17. Role of carrier ligand in platinum resistance in L1210 cells.
    Gibbons GR, Page JD, Mauldin SK, Husain I, Chaney SG.
    Cancer Res; 1990 Oct 15; 50(20):6497-501. PubMed ID: 2208108
    [Abstract] [Full Text] [Related]

  • 18. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR.
    J Inorg Biochem; 2005 Mar 15; 99(3):795-804. PubMed ID: 15708801
    [Abstract] [Full Text] [Related]

  • 19. Effects of diethyldithiocarbamate (DDTC) on the plasma biotransformations of tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in Fischer 344 rats.
    Carfagna PF, Wyrick SD, Holbrook DJ, Chaney SG.
    J Biochem Toxicol; 1991 Mar 15; 6(1):71-80. PubMed ID: 1652641
    [Abstract] [Full Text] [Related]

  • 20. Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity.
    Shord SS, Bernard SA, Lindley C, Blodgett A, Mehta V, Churchel MA, Poole M, Pescatore SL, Luo FR, Chaney SG.
    Anticancer Res; 2002 Mar 15; 22(4):2301-9. PubMed ID: 12174918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.